A team of Researchers from the Center for Neuroscience and Cell Biology (CNC) developed a nanoparticle capable of delivering therapeutic molecules to malignant brain tumors, which are generally associated with a short life expectancy after diagnosis.
The publication of the study, lead by the CNC researcher Conceição Pedroso de Lima, is the result of four years of work on the development of a new therapy for glioblastoma, a highly malignant and lethal type of brain tumor.
